Blair William & Co. IL boosted its position in shares of Revance Therapeutics, Inc. (NASDAQ:RVNC – Free Report) by 144.5% in the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 306,877 shares of the biopharmaceutical company’s stock after acquiring an additional 181,372 shares during […]
Revance Therapeutics, Inc (NASDAQ:RVNC) Given Consensus Rating of Moderate Buy by Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com assumed coverage on shares of Revance Therapeutics (NASDAQ:RVNC – Free Report) in a research report report published on Thursday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other research analysts have also recently issued research reports about the company. Morgan Stanley reduced their price target on Revance Therapeutics from $26.00 […]
Revance Therapeutics, Inc. (NASDAQ:RVNC – Get Free Report) reached a new 52-week low during mid-day trading on Thursday . The stock traded as low as $17.89 and last traded at $17.89, with a volume of 614736 shares changing hands. The stock had previously closed at $18.75. Wall Street Analysts Forecast Growth RVNC has been the […]
Versapay Appoints Spencer Robinson as General Counsel finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.